Fulgent Genetics

-$0.54 (-0.64%) As of 4:32 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FLGT and other ETFs, options, and stocks.

About FLGT

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions.

CEO

Ming Hsieh

Employees

429

Headquarters

Temple City, California

Founded

2016

FLGT Key Statistics

Market Cap

2.49B

Price-Earnings Ratio

4.90

Dividend Yield

—

Average Volume

397.85K

High Today

$85.03

Low Today

$82.70

Open Price

$84.35

Volume

71.30K

52 Week High

$189.89

52 Week Low

$30.05

FLGT News

Simply Wall StOct 16

These 4 Measures Indicate That Fulgent Genetics Is Using Debt Safely

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky

FLGT Earnings

-$0.03

$2.18

$4.38

$6.59

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 8, After Hours

Why Robinhood?

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. View more

These 4 Measures Indicate That Fulgent Genetics Is Using Debt Safely

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions.